Stoke Therapeutics
Stoke Therapeutics is a biopharma company that develops RNA-targeted treatments for severe genetic diseases.
3
Funding Rounds
$235.1m
Money raised
Overview
Stoke Therapeutics is a biopharma company that develops RNA-targeted treatments for severe genetic diseases.
-
Website:
- Business model: B2B B2C
- Social accounts:
| Name | Phone | Social networks | |
|---|---|---|---|
| Ed**** Ka** | - | - | |
| Je* Bu* | - | - | - |
| Ar**** Le*** | - | - | - |
| Ar**** Tz** | - | - | |
| Se** L. Ha* | - | - | - |
| Ga*** Me**** | - | - |
Funding series
Funding Series Analysis
The company Stoke Therapeutics has raised a total of $40m in funding over 3 rounds.
Key Insights:
- Stoke Therapeutics Series A round, January 2017: $40m
- Stoke Therapeutics Venture round, November 2020: $105.1m
- Stoke Therapeutics funding round, October 2018: $90m
Stoke Therapeutics Series A round, January 2017
$40m
Stoke Therapeutics Venture round, November 2020
$105.1m
Stoke Therapeutics funding round, October 2018
$90m
Industries
Stoke Therapeutics is active in the following industries: